Previous 10 | Next 10 |
Paragon 28 (NYSE:FNA): Q3 Non-GAAP EPS of -$0.12 misses by $0.05. Revenue of $35.85M (+18.5% Y/Y) beats by $0.91M. Press Release For further details see: Paragon 28 EPS misses by $0.05, beats on revenue
Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, announced today that Albert DaCosta, Chairman and CEO and Steve Deitsch, CFO will virtually present at the Piper Sandler 33 rd Annual...
Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today reported financial results for the quarter and nine months ended September 30, 2021. Financial Highlights Net revenue...
Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced today that the U.S. Food and Drug Administration (FDA) has given 501(k) marketing clearance to its Circular External Fixa...
Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, announced it will report financial results for the third quarter of 2021 before market open on Monday, November 22, 2021. The company...
You can read full article here. For further details see: Wall Street Breakfast: The Week Ahead (Podcast)
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Economic reports in the week ahead The rush of earnings reports slows down just a bit in the week ahead, but still sees big names like Disney (NYSE:DIS), U...
Get ahead of the market by subscribing to Seeking Alpha's Stocks to Watch, a preview of key events scheduled for the coming week. The newsletter keeps you informed of the biggest stories set to make headlines, including upcoming IPOs, investor days, earnings reports and conference presentatio...
Shares of Paragon 28 Inc. (NYSE:FNA) traded today at $24.47, eclipsing its 52-week high. Approximately 84,000 shares have changed hands today, as compared to an average 30-day volume of 263,000 shares. Paragon 28 Inc. share prices have moved between a 52-week high of $24.47 and a 52-week...
Shares of Paragon 28 Inc. (NYSE:FNA) traded today at $23.00, eclipsing its 52-week high. So far today approximately 81,000 shares have been exchanged, as compared to an average 30-day volume of 256,000 shares. Over the past year, Paragon 28 Inc. has traded in a range of $17.25 to $23.00 ...
News, Short Squeeze, Breakout and More Instantly...
Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, announced it will report financial results for the second quarter 2024 after market close on Thursday, August 8, 2024. The Company’s managem...
2024-06-11 17:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-11 02:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...